Abstract
Tuberculosis still a major problem in Sudan and the anti tuberculosis
drugs continue to be problematic in a systemic manner, which affect the
liver leads to hepatotoxicity and elevation of liver parameter .
The aim of the study to determine the levels of albumin and GGT in
patients with tuberculosis under treatment and compare the level of
albumin and GGT according to sex and type of drugs. This study was
conducted at Kassala state during April to July 2017. In this study eighty
blood samples were tested, sixty samples from known patients with TB
under treatment and twenty control samples.
The study demonstrated that albumin was significantly decreased among
TB patients under treatment compared to control group (Mean±SD:
2.96±0.48g/dl) for cases and (Mean±SD:4.45±0.59 g/dl) for control group
with P.Value 0.000 .
GGT was significantly increased among TB patients under treatment
compared with control group (Mean±SD:87.60±39.29IU/L) for cases
(Mean±SD:17.00±3.45 IU/L) for control group with P.Value 0.000 . Also
the finding of this study showed that albumin was significantly decreased
in patients under medication with rifampin compared with control group (
Mean ± SD: 3.17± 0.48 g/dl) for cases and (Mean±SD:4.45±0.59 g/dl) for
control group with P.Value 0.004. Also albumin show significant
decrease in patients under mixed medication with rifampin and
ethumbutol compared with control group (Mean±SD:2.73±0.30 g/dl) for
cases and (Mean±SD:4.45±0.59 g/dl) for control group with P.Value
0.007.Albumin also show significant decrease in patients under mixed
medication with rifampin, ethumbutol and pyrazinamide compared with
control group ( Mean ± SD:2.81 ±0.45 g/dl ) for cases and (Mean ± SD
:4.45±0.58 g/dl ) for control with P.Value 0.006 .
GGT showed a significant increase in all patients using different (single
or mixed) types of TB treatment (RIF, RIF+EMB, RIF+EMB+PZA),
P.value (0.004, 0.000, 0.001) respectively.
It is concluded that: using Rifampin and Ethumbutol together for
treatment of TB lead to significant changes in albumin and GGT levels.
Awad, A (2021). Assessment of Serum Gamma Glutamyl Transferase and Albumin levels among Patients with Tuberculosis under Treatments. Afribary. Retrieved from https://afribary.com/works/assessment-of-serum-gamma-glutamyl-transferase-and-albumin-levels-among-patients-with-tuberculosis-under-treatments
Awad, Adil "Assessment of Serum Gamma Glutamyl Transferase and Albumin levels among Patients with Tuberculosis under Treatments" Afribary. Afribary, 19 May. 2021, https://afribary.com/works/assessment-of-serum-gamma-glutamyl-transferase-and-albumin-levels-among-patients-with-tuberculosis-under-treatments. Accessed 18 Dec. 2024.
Awad, Adil . "Assessment of Serum Gamma Glutamyl Transferase and Albumin levels among Patients with Tuberculosis under Treatments". Afribary, Afribary, 19 May. 2021. Web. 18 Dec. 2024. < https://afribary.com/works/assessment-of-serum-gamma-glutamyl-transferase-and-albumin-levels-among-patients-with-tuberculosis-under-treatments >.
Awad, Adil . "Assessment of Serum Gamma Glutamyl Transferase and Albumin levels among Patients with Tuberculosis under Treatments" Afribary (2021). Accessed December 18, 2024. https://afribary.com/works/assessment-of-serum-gamma-glutamyl-transferase-and-albumin-levels-among-patients-with-tuberculosis-under-treatments